First ever CRISPR gene therapy approval: What happens next?
BioSpace · BioSpace
November 21, 202313m 24s
Audio is streamed directly from the publisher (api.riverside.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Last Thursday, the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) approved CRISPR/Cas9 gene-edited therapy exagamglogene autotemcel (exa-cel). Will the FDA follow suit? What can patients expect the price tag to be?
Plus, a good handful of approvals for AstraZeneca, Pfizer and Astellas' Xtandi, and Keytruda.
Join BioSpace's Lori Ellis, Greg Slabodkin and Heather McKenzie as they discuss the news this week.